Related Articles
Antitumor effect of cetuximab in combination with S-1 in EGFR-amplified gastric cancer cells
Anti-epidermal growth factor receptor monoclonal antibody cetuximab inhibits EGFR/HER-2 heterodimerization and activation
Integrin β4 reduces DNA damage‑induced p53 activation in colorectal cancer
Mechanisms underlying resistance to cetuximab in the HNSCC cell line: Role of AKT inhibition in bypassing this resistance
Concurrent biological targeting therapy of squamous cell carcinoma of the esophagus with cetuximab and trastuzumab